A detailed history of State Of Michigan Retirement System transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, State Of Michigan Retirement System holds 73,623 shares of VRTX stock, worth $34.2 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
73,623
Previous 73,923 0.41%
Holding current value
$34.2 Million
Previous $34.6 Million 1.18%
% of portfolio
0.17%
Previous 0.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$460.0 - $505.78 $138,000 - $151,734
-300 Reduced 0.41%
73,623 $34.2 Million
Q2 2024

Jul 26, 2024

BUY
$392.81 - $485.53 $314,248 - $388,424
800 Added 1.09%
73,923 $34.6 Million
Q1 2024

Apr 18, 2024

BUY
$407.69 - $446.08 $40,769 - $44,608
100 Added 0.14%
73,123 $30.6 Million
Q4 2023

Jan 22, 2024

BUY
$343.0 - $410.68 $34,300 - $41,068
100 Added 0.14%
73,023 $29.7 Million
Q3 2023

Oct 27, 2023

SELL
$338.18 - $362.46 $202,908 - $217,476
-600 Reduced 0.82%
72,923 $25.4 Million
Q2 2023

Jul 26, 2023

SELL
$314.42 - $351.91 $94,326 - $105,573
-300 Reduced 0.41%
73,523 $25.9 Million
Q1 2023

Apr 28, 2023

BUY
$283.23 - $323.1 $254,907 - $290,790
900 Added 1.23%
73,823 $23.3 Million
Q4 2022

Jan 27, 2023

SELL
$285.76 - $321.48 $142,880 - $160,740
-500 Reduced 0.68%
72,923 $0
Q3 2022

Oct 24, 2022

BUY
$273.83 - $305.53 $109,532 - $122,211
400 Added 0.55%
73,423 $21.3 Million
Q2 2022

Aug 08, 2022

BUY
$234.96 - $292.55 $2.07 Million - $2.57 Million
8,800 Added 13.7%
73,023 $20.6 Million
Q1 2022

May 04, 2022

BUY
$221.42 - $260.97 $41,848 - $49,323
189 Added 0.3%
64,223 $16.8 Million
Q4 2021

Jan 27, 2022

SELL
$177.01 - $223.45 $194,711 - $245,795
-1,100 Reduced 1.69%
64,034 $14.1 Million
Q3 2021

Oct 27, 2021

BUY
$181.39 - $202.99 $18,139 - $20,299
100 Added 0.15%
65,134 $11.8 Million
Q2 2021

Jul 27, 2021

SELL
$187.49 - $221.1 $37,498 - $44,220
-200 Reduced 0.31%
65,034 $13.1 Million
Q1 2021

May 03, 2021

SELL
$207.02 - $241.31 $41,404 - $48,262
-200 Reduced 0.31%
65,234 $14 Million
Q4 2020

Feb 01, 2021

SELL
$207.01 - $276.09 $24.5 Million - $32.7 Million
-118,500 Reduced 64.43%
65,434 $15.5 Million
Q3 2020

Oct 26, 2020

BUY
$255.65 - $303.1 $5.24 Million - $6.21 Million
20,500 Added 12.54%
183,934 $50.1 Million
Q2 2020

Jul 29, 2020

BUY
$225.48 - $295.8 $4.61 Million - $6.05 Million
20,466 Added 14.32%
163,434 $47.4 Million
Q1 2020

May 01, 2020

BUY
$199.77 - $247.81 $21.8 Million - $27 Million
108,949 Added 320.26%
142,968 $34 Million
Q1 2020

Apr 28, 2020

SELL
$199.77 - $247.81 $22.4 Million - $27.8 Million
-112,149 Reduced 76.73%
34,019 $8.09 Million
Q4 2019

Jan 24, 2020

BUY
$166.71 - $223.91 $66,684 - $89,564
400 Added 0.27%
146,168 $32 Million
Q3 2019

Oct 22, 2019

BUY
$166.23 - $187.09 $9.39 Million - $10.6 Million
56,500 Added 63.29%
145,768 $24.7 Million
Q2 2019

Jul 26, 2019

SELL
$164.61 - $190.37 $8.63 Million - $9.98 Million
-52,400 Reduced 36.99%
89,268 $16.4 Million
Q1 2019

May 06, 2019

BUY
$163.73 - $194.7 $1.39 Million - $1.65 Million
8,500 Added 6.38%
141,668 $26.1 Million
Q4 2018

Feb 01, 2019

BUY
$151.91 - $192.21 $8.66 Million - $11 Million
57,000 Added 74.83%
133,168 $22.1 Million
Q3 2018

Oct 26, 2018

BUY
$167.73 - $192.74 $117,411 - $134,918
700 Added 0.93%
76,168 $14.7 Million
Q2 2018

Aug 08, 2018

BUY
$145.72 - $169.96 $102,004 - $118,972
700 Added 0.94%
75,468 $12.8 Million
Q1 2018

May 08, 2018

BUY
$151.6 - $177.13 $90,960 - $106,278
600 Added 0.81%
74,768 $12.2 Million
Q4 2017

Feb 01, 2018

SELL
$137.28 - $155.55 $315,744 - $357,765
-2,300 Reduced 3.01%
74,168 $11.1 Million
Q3 2017

Oct 19, 2017

BUY
$148.13 - $162.24 $11.3 Million - $12.4 Million
76,468
76,468 $11.6 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track State Of Michigan Retirement System Portfolio

Follow State Of Michigan Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Michigan Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Of Michigan Retirement System with notifications on news.